<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71-vaccines-07-00070">
 <label>71.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Prager</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Boos</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Resch</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Brizic</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Mach</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wildner</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Scrivano</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Adler</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Human cytomegalovirus glycoprotein complex gH/gL/gO uses PDGFR-Î± as a key for entry</article-title>
  <source>PLoS Pathog.</source>
  <year>2017</year>
  <volume>13</volume>
  <elocation-id>e1006281</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.ppat.1006281</pub-id>
  <pub-id pub-id-type="pmid">28403202</pub-id>
 </element-citation>
</ref>
